Form D · Biotechnology
Heartpoint Global Inc.
Coral Gables, FL · CIK 0001792364
Offering snapshot reported May 14, 2020 · SEC filing
- Reported sold
- $3.33M Offering amount: $3.33M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 31, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 14, 2020 | Initial | $3,330,495 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-366939
3,330,495 shares of common stock issued in share exchange with all stockholders of indirect parent company of the Issuer, resulting in Issuer becoming the parent of a company group.
No commissions or finders' fees paid or due in connection with the share exchange
Source: Form D, filed May 14, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Seth Bogner | Director, Executive |
| Paul Price | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
One Alhambra Plaza Ph Level
Coral Gables, FL, 33134
Coral Gables, FL, 33134